LED Treatment to Improve Cognition and Promote Recovery in TBI (LED-TBI)
Status
Conditions
Treatments
Details and patient eligibility
About
This study investigates the efficacy of a novel neuromodulation treatment, light emitting diodes (LED), on cognition, neuropsychiatric status and quality of life in individuals with traumatic brain injury (TBI).
Full description
The most common traumatic brain injury (TBI)-associated problems are cognitive deficits and neuropsychiatric problems, such as sleep disturbance and PTSD. This study evaluates a novel neuromodulation intervention, light emitting diodes (LED), for treatment of patients with TBI. LED is a noninvasive, non-thermal, painless treatment, which does not involve any needles or any form of surgery. LED treatment improves cellular activity of the brain tissue that has been damaged by TBI. Half of the study participants will receive active LED treatment, and a control group will receive sham LED. This study takes place in Boston, Massachusetts: at the VA Boston Healthcare System.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Inclusion Criteria:
- OEF/OIF active-duty personnel or Veterans with history of TBI or blast-exposure
- Meets criteria for mild TBI
- LOC of 30 min or less
- Age: 21-55
- Primary language is English
Exclusion criteria
- Evidence of penetrating head injury
- History of previous neurological diagnosis
- History of previous psychotic disorder prior to TBI
- Hearing or vision impairment
Trial design
Primary purpose
Allocation
Interventional model
Masking
8 participants in 2 patient groups
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal